MedTrace Logo

Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer

NCT06982391 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-21

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effects of an Acceptance and Commitment Therapy (ACT) based program (ReACT) to increase social support, compassion and psychological flexibility on psychological resilience in women undergoing mastectomy. The main question it aims to answer is: Does the ReACT program improve participants' resilience by increasing social support, compassion, and psychological flexibility? Researchers will compare intervention group to control group to see if ReACT program works to improve participants' resilience.

Researchers will randomly divide participants into two groups: intervention group and control group.

* Participants will complete some questionnaires.
* Participants in the intervention group will join a 3-week ACT-based psychological flexibility program. This program consists of sessions that last 90 minutes each. The program adopts the core principles of ACT and aims to help participants develop skills in mindfulness, acceptance, value-driven living, and cognitive defusion.
* Participants will complete the same questionnaires again after the program.
* Participants will complete the same questionnaires again 1 month after the program ends.

Conditions

  • Breast Cancer Survivor
  • Mastectomy

Interventions

BEHAVIORAL

Resilience-Focused Acceptance and Commitment Therapy (ReACT) Program

The Resilience-Focused Acceptance and Commitment Therapy (ReACT) program is a structured, group-based psychological intervention specifically designed for women who have undergone mastectomy following breast cancer. The program consists of three weekly 90-minute sessions integrating core ACT processes, including acceptance, defusion, mindfulness, values clarification, and committed action, with an emphasis on building psychological resilience, self-compassion, and enhancing perceived social support. The program uniquely combines evidence-based ACT techniques with group exercises focused on post-cancer psychosocial adjustment.

OTHER

No intervention

Standard Care

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Principal Investigators

  • Ela Arı, Assistant Professor · Medipol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-12
Primary Completion
2026-01-15
Completion
2026-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06982391 on ClinicalTrials.gov